Keywords: medicines, co, sees, 3rd-qtr, sales, rocket, new
The Medicines Co sees 3rd-qtr sales rocket 77%
Article | 25 October 2004
New Jersey, USA-headquartered The Medicines Company generated a 77% increase in third-quarter 2004 sales to $37.7 million.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
